Michelle Tew

221 posts

Michelle Tew banner
Michelle Tew

Michelle Tew

@michelletsp

Health Economics Senior Research Fellow @HEU_unimelb @HealthPolicyUoM @unimelbMSPGH | Group Leader of Health Technology Assessment (PBAC) M-VAC

Melbourne, Victoria Katılım Mart 2016
327 Takip Edilen612 Takipçiler
Sabitlenmiş Tweet
Michelle Tew
Michelle Tew@michelletsp·
Article on Incorporating future medical costs: Impact on #costeffectiveness of #sepsis intervention in #cancer patients show it’s impact varies across cancer types and longer life expectancies did not necessarily result in greater lifetime healthcare costs doi.org/10.1007/s40273…
Michelle Tew tweet media
English
3
5
11
0
Michelle Tew retweetledi
Australian Health Economics Society
New Job Listing on the AHES website: Research Fellow/Senior Research Fellow (HTA), The University of Melbourne For more information visit: Jobs - Australian Health Economics Society (ahes.org.au)
English
0
2
8
477
Michelle Tew retweetledi
Melbourne Health Economics
Melbourne Health Economics@HEU_unimelb·
Research Assistant/Research Fellow, Health Technology Assessment role at Melbourne Health Technology and Value Assessment Collaboration (M-VAC) - Melbourne Health Economics, University of Melbourne jobs.unimelb.edu.au/caw/en/job/915… Applications close 4th March.
English
1
4
6
682
Michelle Tew
Michelle Tew@michelletsp·
Andrew Wilson #HTAiAdelaide2023 indicated that compared to other OECD countries, Australia falls behind in access and equity of health technologies. What can we do better?
English
0
2
2
250
Michelle Tew
Michelle Tew@michelletsp·
Fascinating work showcasing living network meta-analysis to consolidate evidence from multiple clinical trials with different treatment regiments for prostrate cancer. Care is needed to account for heterogeneity #HTAiAdelaide2023
Michelle Tew tweet mediaMichelle Tew tweet mediaMichelle Tew tweet media
English
0
2
5
331
Michelle Tew
Michelle Tew@michelletsp·
Time to consider reference models for HTA? Interesting talk by Hossein Afzali. Structural uncertainty often not assessed. Empirical evidence has shown that it can have greater impact on CEA results compared to parameter uncertainty. #HTAiAdelaide2023 #HealthEconomics
Michelle Tew tweet mediaMichelle Tew tweet media
English
1
3
7
591
Michelle Tew
Michelle Tew@michelletsp·
Balancing speed and rigor. Fascinating debate from multiple perspectives on how to get novel innovative tech to patients sooner #HTAiAdelaide2023 Some key considerations- accounting for spillover effects to careers, use of RWE
Michelle Tew tweet media
English
0
2
9
575
Michelle Tew
Michelle Tew@michelletsp·
Excited to be attending #HTAi2023Adelaide this week starting with a workshop on hospital-based HTA. Lots of interesting insights shared by key experts in this area particularly around importance of stakeholder buy-in, engaging the right clinicians to collaborate with.
Michelle Tew tweet mediaMichelle Tew tweet media
English
0
4
12
768
Michelle Tew
Michelle Tew@michelletsp·
📣 New paper alert! Recruitment is no doubt a challenge for any clinical trial. In this paper we developed an economic model to show the trade-offs between time and cost, or both, when recruitment is lower than anticipated. Spoiler alert. It’s costly! link.springer.com/article/10.100…
English
1
4
16
2.8K